Medak District, India

Ravi Kumar Mylavarapu

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ravi Kumar Mylavarapu. Retrieved from https://idiyas.com/inventor/ravi-kumar-mylavarapu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ravi Kumar Mylavarapu

Introduction

Ravi Kumar Mylavarapu is a notable inventor based in Medak District, India. He has made significant contributions to the field of pharmaceuticals, particularly with his work on bazedoxifene, a drug compound with promising therapeutic applications.

Latest Patents

Mylavarapu holds a patent for the "Preparation of crystalline bazedoxifene and its salts." This patent includes aspects such as crystalline bazedoxifene free base, crystalline bazedoxifene acetate Form D, and processes for their preparation. The drug compound, known as bazedoxifene acetate, has a complex chemical structure and is recognized for its potential benefits in medical treatments.

Career Highlights

He is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company. His work at Dr. Reddy's has allowed him to focus on innovative drug development and contribute to advancements in healthcare.

Collaborations

Mylavarapu has collaborated with several professionals in his field, including Sundra Lakshmi Kanniah and Rajesham Boge. These collaborations have fostered a productive environment for research and development.

Conclusion

Ravi Kumar Mylavarapu's contributions to the pharmaceutical industry, particularly through his patent on bazedoxifene, highlight his role as an innovative inventor. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…